What is the current Iliac Stent market size?

The Iliac Stent market size is approximately USD 1.2 billion as of 2023.

What is the expected growth forecast for the Iliac Stent market?

The market is expected to grow at a CAGR of 5.5% from 2026 to 2033.

What are the key drivers of the Iliac Stent market?

Increasing demand for minimally invasive procedures drives the market.

What challenges does the Iliac Stent market face?

Stringent regulatory requirements and high costs are major challenges.

Which regions are leaders in the Iliac Stent market?

North America and Europe are the leading regions in the market.

Who are the top companies in the Iliac Stent market?

Top companies include Medtronic, Boston Scientific, and Abbott Laboratories.

What future opportunities exist in the Iliac Stent market?

Emerging markets and technological advancements offer future growth opportunities.

How does technology impact the Iliac Stent market?

Advances in stent technology improve patient outcomes and drive market growth.

What is the current regulatory landscape for the Iliac Stent market?

The market is regulated by FDA and CE mark approvals in the US and EU.

What is the future outlook for the Iliac Stent market?

The market is expected to grow due to increasing demand for vascular treatments.

Iliac Stent Growth, Trends & Forecast Outlook 2033

Iliac Stent by Application (Hospitals, Outpatient Facilities, Others), by Types (Self-expandable Stents, Balloon-expandable Stents, Others), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 119

Forecast Period: 2026 - 2033

Market Size: $1215 million

CAGR: 5.5%

Historical Range: 2020 - 2025

Dec 21, 2025Updated: Jun 8, 2026

Pages: 119

Forecast Period: 2026 - 2033

Market Size: $1215 million

CAGR: 5.5%

Historical Range: 2020 - 2025

Dec 21, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

Iliac Stent Market Overview

The Iliac Stent market is defined as the global market for stents used to treat iliac artery disease, which is a type of peripheral artery disease. The relevance of this market lies in its potential to improve treatment outcomes for patients with iliac artery disease. As the Iliac Stent market size is estimated to be around $1.3 billion in 2025, the growth outlook for this market is promising, with a projected market forecast of $2.5 billion by 2033. The industry expansion is driven by increasing demand for minimally invasive procedures and advancements in stent technology. The scope of this market encompasses various types of stents, including bare-metal stents, drug-eluting stents, and bioabsorbable stents, which are used in different applications, such as angioplasty and stenting procedures, in various end-user settings, including hospitals and ambulatory surgical centers.

Loading chart…

The Iliac Stent market is expected to grow at a compound annual growth rate (CAGR) of 7.5% from 2026 to 2033, driven by macro drivers such as the increasing prevalence of peripheral artery disease, rising demand for minimally invasive procedures, and advancements in stent technology. Key forces shaping the industry include technology shifts towards more advanced stent materials and designs, regulations governing the approval and use of stents, and competitive intensity among market players. The largest region for the Iliac Stent market is North America, while the fastest-growing region is Asia-Pacific, driven by increasing healthcare expenditure and improving healthcare infrastructure in countries such as China and India.

Report Overview

Report Attribute	Details
Market size value in 2025	1.22 billion
Revenue forecast in 2033	2.12 billion
Growth rate	CAGR of 7.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	BD; Abbott; Boston Scientific Corporation; W. L. Gore & Associates, Inc.; Medtronic; Cook; Terumo Corporation; iVascular; Getinge AB; Biotronik SE & Co KG
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Iliac Stent market is poised for significant growth, driven by factors such as the increasing prevalence of peripheral artery disease and the rising demand for minimally invasive procedures. The Iliac Stent market size is expected to expand substantially, with a growth forecast that indicates a steady upward trend.

Growth Drivers2 items

Advances in stent technology, including the development of drug-eluting and bioabsorbable stents, are driving growth in the Iliac Stent market by providing more effective treatment options for patients.

The growing awareness of the benefits of iliac stenting, including reduced risk of complications and improved patient outcomes, is increasing demand and contributing to the growth forecast of the market.

Restraints2 items

Stringent regulatory requirements and the high cost of iliac stents are major restraints on the Iliac Stent market, limiting access to these devices in some regions and patient populations.

The availability of alternative treatment options, such as angioplasty and bypass surgery, is also a restraint on the market, as some patients and physicians may prefer these alternatives over iliac stenting.

Opportunities2 items

The increasing adoption of iliac stenting in emerging markets, driven by growing healthcare infrastructure and rising demand for cardiovascular treatments, presents a significant opportunity for growth in the Iliac Stent market.

The development of new stent materials and designs, such as nanocoated and 3D-printed stents, is expected to further drive growth and innovation in the market, with a positive impact on the growth forecast.

Challenges2 items

The management of complications associated with iliac stenting, such as stent fracture and restenosis, is a major challenge facing the Iliac Stent market, requiring ongoing research and development to improve patient outcomes.

The need for careful patient selection and pre-procedural planning to ensure optimal results from iliac stenting is another challenge, highlighting the importance of education and training for healthcare professionals in this field.

Market Segmentation

Loading chart…

The Iliac Stent market can be segmented based on Application, which includes subtypes such as peripheral artery disease, aneurysms, and trauma. This segmentation contributes to the overall Iliac Stent market size by identifying specific areas of demand and growth. Understanding the application segmentation is crucial for market players to develop targeted strategies and products that cater to the unique needs of each segment. The Iliac Stent segmentation by application provides valuable insights into the market dynamics and trends, enabling companies to make informed decisions and stay competitive.

The Types of Iliac Stents can be further divided into subtypes, including balloon-expandable stents, self-expanding stents, and covered stents. Each subtype has its own set of characteristics, advantages, and limitations, which impact the overall market size and growth. Analyzing the types of Iliac Stents helps market players to identify opportunities for innovation and differentiation, as well as to develop effective marketing strategies that resonate with their target audience. By examining the market taxonomy of Iliac Stent types, companies can better understand the complex landscape of the industry and make strategic decisions to drive business success.

Iliac Stent Segmentation Breakdown8 items

Application

Hospitals

Outpatient Facilities

Others

Types

Self-expandable Stents

Balloon-expandable Stents

Others

Regional Insights

Loading chart…

The Iliac Stent market growth is anticipated to vary across regions, with North America being the largest region, accounting for approximately 40% of the global market. The fastest-growing region is expected to be Asia Pacific, driven by increasing adoption of iliac stent procedures, favorable policies, and significant investments in healthcare infrastructure.

Key drivers for each region include: for North America, demographics with an aging population, infrastructure with well-established healthcare systems, and ecosystem maturity with high awareness of iliac stent treatments. For Europe, drivers include adoption of advanced medical technologies, policies supporting healthcare innovation, and investments in research and development. Asia Pacific's growth is fueled by demographics with a large and growing population, infrastructure development in healthcare, and increasing adoption of iliac stent procedures. Latin America and Middle East & Africa are driven by infrastructure development, policies supporting healthcare access, and growing adoption of iliac stent treatments.

The regional forecast indicates that the Iliac Stent market will continue to grow, with each region contributing to the global market share. Understanding the key drivers and factors influencing each region's growth is crucial for stakeholders to navigate the Iliac Stent market growth and make informed decisions.

Competitive Landscape

The Iliac Stent market is moderately consolidated, driven by a mix of global players and local/regional companies. The Iliac Stent competitive landscape is characterized by key competitive levers such as pricing, distribution, product innovation, certifications, and regulatory approvals. Global players tend to focus on premium pricing and product innovation, while local companies often prioritize regional expansion and localization.

Companies in the Iliac Stent market employ various strategies to differentiate themselves, including M&A, partnerships, product launches, expansion, R&D, and localization. However, they face challenges such as margin pressure, compliance costs, and commoditization. To stay competitive, companies must focus on technology, service model, channel strength, customization, and cost advantages. The following companies have distinct strategic focuses:

BD: regional expansion

Abbott: innovation pipeline

Boston Scientific Corporation: premium pricing

W. L. Gore & Associates, Inc.: vertical integration

Medtronic: OEM tie-ups

Cook: local manufacturing

Key Iliac Stent Companies10 items

Abbott

Boston Scientific Corporation

W. L. Gore & Associates, Inc.

Medtronic

Cook

Terumo Corporation

iVascular

Getinge AB

Biotronik SE & Co KG

Market Ecosystem

The Iliac Stent ecosystem spans across upstream, midstream, and downstream segments, encompassing technology providers, suppliers, integrators, channels, and end users. Value is created and captured through the development, manufacturing, and distribution of iliac stents, with each participant playing a distinct role in the value chain analysis. The ecosystem boundaries are defined by the flow of goods, services, and information from raw material suppliers to end users, with various stakeholders influencing the creation and capture of value.

Raw material suppliers — providing metals and materials

OEMs / manufacturers — designing and producing iliac stents

Technology providers — developing stent technologies and designs

Distributors / channel partners — delivering products to healthcare facilities

Service providers / after-sales — offering training and support services

End users / buyers — healthcare professionals and institutions

Regulators/standards bodies — establishing safety and efficacy standards

The flow of value in the Iliac Stent ecosystem is influenced by control points, such as regulatory approvals and reimbursement policies, which can impact adoption rates. Dependency risks, including input constraints and standards compliance, can also affect the ecosystem. Furthermore, switching costs, partnerships, and interoperability requirements can create barriers to entry or exit, while regional differences in healthcare systems and regulatory frameworks can result in variations in the Iliac Stent ecosystem across different regions.

Recent Industry Insights

The Iliac Stent industry trends have witnessed significant developments over the last 12-18 months. Recent partnerships between key players have focused on enhancing product portfolios and expanding geographical reach. Notable mergers and acquisitions have also taken place, leading to market consolidation and increased competition. Furthermore, several product and technology launches have been observed, showcasing advancements in stent design, materials, and deployment techniques.

Regulatory changes have also impacted the industry, with updated guidelines and standards influencing product development and approval processes. A notable shift in consumer trends has been observed, with increasing demand for minimally invasive procedures and personalized treatment options. Additionally, funding rounds and expansions have been reported, enabling companies to invest in research and development, and-scale up production to meet growing demand.

Analyst Overview

As the Lead Analyst for this study, I provide an expert view on the Iliac Stent market. The Iliac Stent market outlook is promising, driven by an increasing prevalence of peripheral artery disease and advancements in stent technology. The market exhibits moderate competitive intensity, with key players focusing on innovation and expansion into emerging markets. The long-term outlook is favorable, with growing demand for minimally invasive procedures. However, the market is not without risks, including key risk factors such as regulatory challenges and reimbursement issues. Overall, the demand–supply balance is expected to remain stable, with manufacturers investing in research and development to address the evolving needs of the market.

12 items

1. Executive Summary

2. Iliac Stent Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Iliac Stent Market Product Outlook & Forecast (2021-2033) Value (USD Million) & Volume (K)

6.1. Global Iliac Stent Market Product Outlook & Forecast (2021-2033) Value (USD Million)

6.1.1. Global Iliac Stent Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.2. Global Iliac Stent Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.1.3. Global Iliac Stent Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

6.2. Global Iliac Stent Market Product Outlook & Forecast (2021-2033) Volume (K)

6.2.1. Global Iliac Stent Market Volume (K) and CAGR (%) by Application (2020-2032)

6.2.2. Global Iliac Stent Market Volume (K) and CAGR (%) by Types (2020-2032)

6.2.3. Global Iliac Stent Market Volume (K) and CAGR (%) by Region (2020-2032)

7. Global Iliac Stent Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Iliac Stent Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Iliac Stent Market Breakdown Data By Volume (K) (2020-2032)

8.1. Global Iliac Stent Market by: Regions (Volume)

8.1.1. North America

8.1.2. South America

8.1.3. Europe

8.1.4. Middle East & Africa

8.1.5. Asia Pacific

8.2. North America

8.2.1. North America Volume (K) (2020-2032) By Country

8.2.2. North America Volume (K) (2020-2032) by Application

8.2.3. North America Volume (K) (2020-2032) by Types

8.3. South America

8.3.1. South America Volume (K) (2020-2032) By Country

8.3.2. South America Volume (K) (2020-2032) by Application

8.3.3. South America Volume (K) (2020-2032) by Types

8.4. Europe

8.4.1. Europe Volume (K) (2020-2032) By Country

8.4.2. Europe Volume (K) (2020-2032) by Application

8.4.3. Europe Volume (K) (2020-2032) by Types

8.5. Middle East & Africa

8.5.1. Middle East & Africa Volume (K) (2020-2032) By Country

8.5.2. Middle East & Africa Volume (K) (2020-2032) by Application

8.5.3. Middle East & Africa Volume (K) (2020-2032) by Types

8.6. Asia Pacific

8.6.1. Asia Pacific Volume (K) (2020-2032) By Country

8.6.2. Asia Pacific Volume (K) (2020-2032) by Application

8.6.3. Asia Pacific Volume (K) (2020-2032) by Types

9. Global Iliac Stent Market Competition by Key Manufacturers

9.1. Global Iliac Stent Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

9.2. Player's Concentration

9.2.1. Top 5 Manufacturers

9.2.2. Top 3 Manufacturers

9.3. Market Entropy

Global Iliac Stent: Profiled Players Head Office and Area Served

9.4. Key Player Products/Services

9.4.1 Merger & Acquisitions and Expansion Plans

10. Company Profile

10.1. BD

10.1.1. Company Basic Information and Sales Area

10.1.2. Main Business/Business Overview

10.1.3. Product Portfolio

10.1.4. Financial

10.1.5. Recent Industry Insights

10.1.6. SWOT Analysis

10.2. Abbott

10.2.1. Company Basic Information and Sales Area

10.2.2. Main Business/Business Overview

10.2.3. Product Portfolio

10.2.4. Financial

10.2.5. Recent Industry Insights

10.2.6. SWOT Analysis

10.3. Boston Scientific Corporation

10.3.1. Company Basic Information and Sales Area

10.3.2. Main Business/Business Overview

10.3.3. Product Portfolio

10.3.4. Financial

10.3.5. Recent Industry Insights

10.3.6. SWOT Analysis

10.4. W. L. Gore & Associates, Inc.

10.4.1. Company Basic Information and Sales Area

10.4.2. Main Business/Business Overview

10.4.3. Product Portfolio

10.4.4. Financial

10.4.5. Recent Industry Insights

10.4.6. SWOT Analysis

10.5. Medtronic

10.5.1. Company Basic Information and Sales Area

10.5.2. Main Business/Business Overview

10.5.3. Product Portfolio

10.5.4. Financial

10.5.5. Recent Industry Insights

10.5.6. SWOT Analysis

10.6. Cook

10.6.1. Company Basic Information and Sales Area

10.6.2. Main Business/Business Overview

10.6.3. Product Portfolio

10.6.4. Financial

10.6.5. Recent Industry Insights

10.6.6. SWOT Analysis

10.7. Terumo Corporation

10.7.1. Company Basic Information and Sales Area

10.7.2. Main Business/Business Overview

10.7.3. Product Portfolio

10.7.4. Financial

10.7.5. Recent Industry Insights

10.7.6. SWOT Analysis

10.8. iVascular

10.8.1. Company Basic Information and Sales Area

10.8.2. Main Business/Business Overview

10.8.3. Product Portfolio

10.8.4. Financial

10.8.5. Recent Industry Insights

10.8.6. SWOT Analysis

10.9. Getinge AB

10.9.1. Company Basic Information and Sales Area

10.9.2. Main Business/Business Overview

10.9.3. Product Portfolio

10.9.4. Financial

10.9.5. Recent Industry Insights

10.9.6. SWOT Analysis

10.10. Biotronik SE & Co KG

10.10.1. Company Basic Information and Sales Area

10.10.2. Main Business/Business Overview

10.10.3. Product Portfolio

10.10.4. Financial

10.10.5. Recent Industry Insights

10.10.6. SWOT Analysis

11. Methodology/Research Approach

11.1. Research Programs/Material Type

11.2. Market Size Estimation

11.3. Market Breakdown and Data Triangulation

12. Data Sources

12.1. Secondary Sources

12.2. Primary Sources

List of Figures

40 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Iliac Stent Market

Figure 4: Global Iliac Stent Market: Drivers

Figure 5: Global Iliac Stent Market: Challenges

Figure 6: Global Iliac Stent Market: Trends

Figure 7: Global Iliac Stent Market: Opportunity

Figure 8: Global Iliac Stent Market: Restraint

Figure 9: Global Iliac Stent Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Market Volume (K) (2020-2024) By Application

Figure 15: Global Market Share (%) By Application (2024)

Figure 16: Global Market Volume (K) (2020-2024) By Types

Figure 17: Global Market Share (%) By Types (2024)

Figure 18: Global Iliac Stent Market Value (USD Million) By Region

Figure 19: Global Iliac Stent Market Share (%) By: Regions (2024)

Figure 20: Top 5 Manufacturers

Figure 21: Top 3 Manufacturers

Figure 22: Global Market Value (USD Million) (2025-2032) By Application

Figure 23: Global Market Share (%) By Application (2032)

Figure 24: Global Market Value (USD Million) (2025-2032) By Types

Figure 25: Global Market Share (%) By Types (2032)

Figure 26: Global Iliac Stent Market Value (USD Million) By Region

Figure 27: Global Iliac Stent Market Share (%) By: Regions (2032)

Figure 28: Global Iliac Stent Market Volume (K) By Region

Figure 29: Global Iliac Stent Market Share (%) By: Regions (2024)

Figure 30: Top 5 Manufacturers

Figure 31: Top 3 Manufacturers

Figure 32: Global Market Volume (K) (2025-2032) By Application

Figure 33: Global Market Share (%) By Application (2032)

Figure 34: Global Market Volume (K) (2025-2032) By Types

Figure 35: Global Market Share (%) By Types (2032)

Figure 36: Global Iliac Stent Market Value (USD Million) By Region

Figure 37: Global Iliac Stent Market Share (%) By: Regions (2032)

Figure 38: Global Iliac Stent Market Volume (K) By Region

Figure 39: Global Iliac Stent Market Share (%) By: Regions (2032)

Figure 40: Data Triangulation

List of Tables

115 items

Table 1: Market Segmentation Analysis

Table 2: Global Iliac Stent Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Iliac Stent Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Iliac Stent Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Market Volume (K) (2020-2024) By Application

Table 10: Global Market Share (%) By Application (2024)

Table 11: Global Market Volume (K) (2020-2024) By Types

Table 12: Global Market Share (%) By Types (2024)

Table 13: Global Iliac Stent Market Value (USD Million) By Region

Table 14: Global Iliac Stent Market Share (%) By Region

Table 15: North America Market Value (USD Million) (2020-2024) By Country

Table 16: North America Market Value (USD Million) (2020-2024) By Application

Table 17: North America Market Value (USD Million) (2020-2024) By Types

Table 18: Europe Market Value (USD Million) (2020-2024) By Country

Table 19: Europe Market Value (USD Million) (2020-2024) By Application

Table 20: Europe Market Value (USD Million) (2020-2024) By Types

Table 21: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 22: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 23: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 24: South America Market Value (USD Million) (2020-2024) By Country

Table 25: South America Market Value (USD Million) (2020-2024) By Application

Table 26: South America Market Value (USD Million) (2020-2024) By Types

Table 27: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 28: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 29: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 30: Global Iliac Stent Market Volume (K) By Region

Table 31: Global Iliac Stent Market Share (%) By Region

Table 32: North America Market Volume (K) (2020-2024) By Country

Table 33: North America Market Volume (K) (2020-2024) By Application

Table 34: North America Market Volume (K) (2020-2024) By Types

Table 35: Europe Market Volume (K) (2020-2024) By Country

Table 36: Europe Market Volume (K) (2020-2024) By Application

Table 37: Europe Market Volume (K) (2020-2024) By Types

Table 38: Asia Pacific Market Volume (K) (2020-2024) By Country

Table 39: Asia Pacific Market Volume (K) (2020-2024) By Application

Table 40: Asia Pacific Market Volume (K) (2020-2024) By Types

Table 41: South America Market Volume (K) (2020-2024) By Country

Table 42: South America Market Volume (K) (2020-2024) By Application

Table 43: South America Market Volume (K) (2020-2024) By Types

Table 44: Middle East & Africa Market Volume (K) (2020-2024) By Country

Table 45: Middle East & Africa Market Volume (K) (2020-2024) By Application

Table 46: Middle East & Africa Market Volume (K) (2020-2024) By Types

Table 47: Global Iliac Stent Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 48: Global Iliac Stent Market: Profiled Players Head Office And Area Served

Table 49: Key Players Global Iliac Stent Market:

Table 50: Mergers & Acquisitions, Expansion Plans

Table 51: BD Basic Information And Sales Area

Table 52: BD. Products Portfolio

Table 53: Abbott Basic Information And Sales Area

Table 54: Abbott. Products Portfolio

Table 55: Boston Scientific Corporation Basic Information And Sales Area

Table 56: Boston Scientific Corporation. Products Portfolio

Table 57: W. L. Gore & Associates, Inc. Basic Information And Sales Area

Table 58: W. L. Gore & Associates, Inc.. Products Portfolio

Table 59: Medtronic Basic Information And Sales Area

Table 60: Medtronic. Products Portfolio

Table 61: Cook Basic Information And Sales Area

Table 62: Cook. Products Portfolio

Table 63: Terumo Corporation Basic Information And Sales Area

Table 64: Terumo Corporation. Products Portfolio

Table 65: iVascular Basic Information And Sales Area

Table 66: iVascular. Products Portfolio

Table 67: Getinge AB Basic Information And Sales Area

Table 68: Getinge AB. Products Portfolio

Table 69: Biotronik SE & Co KG Basic Information And Sales Area

Table 70: Biotronik SE & Co KG. Products Portfolio

Table 71: Global Market Value (USD Million) (2025-2032) By Application

Table 72: Global Market Share (%) By Application (2032)

Table 73: Global Market Value (USD Million) (2025-2032) By Types

Table 74: Global Market Share (%) By Types (2032)

Table 75: Global Market Volume (K) (2025-2032) By Application

Table 76: Global Market Share (%) By Application (2032)

Table 77: Global Market Volume (K) (2025-2032) By Types

Table 78: Global Market Share (%) By Types (2032)

Table 79: Global Iliac Stent Market Value (USD Million) By Region

Table 80: Global Iliac Stent Market Share (%) By Region (2025-2032)

Table 81: North America Market Value (USD Million) (2025-2032) By Country

Table 82: North America Market Value (USD Million) (2025-2032) By Application

Table 83: North America Market Value (USD Million) (2025-2032) By Types

Table 84: Europe Market Value (USD Million) (2025-2032) By Country

Table 85: Europe Market Value (USD Million) (2025-2032) By Application

Table 86: Europe Market Value (USD Million) (2025-2032) By Types

Table 87: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 88: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 89: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 90: South America Market Value (USD Million) (2025-2032) By Country

Table 91: South America Market Value (USD Million) (2025-2032) By Application

Table 92: South America Market Value (USD Million) (2025-2032) By Types

Table 93: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 94: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 95: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 96: Global Iliac Stent Market Volume (K) By Region

Table 97: Global Iliac Stent Market Share (%) By Region (2025-2032)

Table 98: North America Market Volume (K) (2025-2032) By Country

Table 99: North America Market Volume (K) (2025-2032) By Application

Table 100: North America Market Volume (K) (2025-2032) By Types

Table 101: Europe Market Volume (K) (2025-2032) By Country

Table 102: Europe Market Volume (K) (2025-2032) By Application

Table 103: Europe Market Volume (K) (2025-2032) By Types

Table 104: Asia Pacific Market Volume (K) (2025-2032) By Country

Table 105: Asia Pacific Market Volume (K) (2025-2032) By Application

Table 106: Asia Pacific Market Volume (K) (2025-2032) By Types

Table 107: South America Market Volume (K) (2025-2032) By Country

Table 108: South America Market Volume (K) (2025-2032) By Application

Table 109: South America Market Volume (K) (2025-2032) By Types

Table 110: Middle East & Africa Market Volume (K) (2025-2032) By Country

Table 111: Middle East & Africa Market Volume (K) (2025-2032) By Application

Table 112: Middle East & Africa Market Volume (K) (2025-2032) By Types

Table 113: Research Programs/Design For This Report

Table 114: Key Data Information From Secondary Sources

Table 115: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Iliac Stent Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	1.22 billion
Revenue forecast in 2033	2.12 billion
Growth rate	CAGR of 7.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	BD; Abbott; Boston Scientific Corporation; W. L. Gore & Associates, Inc.; Medtronic; Cook; Terumo Corporation; iVascular; Getinge AB; Biotronik SE & Co KG
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

Restraints2 items

Stringent regulatory requirements and the high cost of iliac stents are major restraints on the Iliac Stent market, limiting access to these devices in some regions and patient populations.

Opportunities2 items

Challenges2 items

Market Segmentation

Loading chart…

Iliac Stent Segmentation Breakdown8 items

Application

Hospitals

Outpatient Facilities

Others

Types

Self-expandable Stents

Balloon-expandable Stents

Others

Regional Insights

Loading chart…

Competitive Landscape

BD: regional expansion

Abbott: innovation pipeline

Boston Scientific Corporation: premium pricing

W. L. Gore & Associates, Inc.: vertical integration

Medtronic: OEM tie-ups

Cook: local manufacturing

Key Iliac Stent Companies10 items

Abbott

Boston Scientific Corporation

W. L. Gore & Associates, Inc.

Medtronic

Cook

Terumo Corporation

iVascular

Getinge AB

Biotronik SE & Co KG

Market Ecosystem

Raw material suppliers — providing metals and materials

OEMs / manufacturers — designing and producing iliac stents

Technology providers — developing stent technologies and designs

Distributors / channel partners — delivering products to healthcare facilities

Service providers / after-sales — offering training and support services

End users / buyers — healthcare professionals and institutions

Regulators/standards bodies — establishing safety and efficacy standards

Recent Industry Insights

Analyst Overview

Table of Contents